
Sangrix Inc. (SGRX) Stock Overview
Explore Sangrix Inc.’s financial performance, market position, analyst ratings, and future outlook.
Sangrix Inc. (SGRX)
Key Financials
Key Financials
Market Cap
1.4M
P/E Ratio
-0.02
EPS (TTM)
$-85.62
ROE
-7.32%
SGRX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Sangrix Inc. (NASDAQ: SGRX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Sangrix Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SGRX on the NASDAQ shows an RSI of 56.91, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.
Key metrics behind Sangrix Inc.'s NASDAQ-traded stock include a P/E ratio of -0.02 and a market capitalization of 1.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SGRX on the NASDAQ.